Responding With Evidence and Access for Childhood Headaches
Start Date
8/22/2023
Completion Date
12/31/2027
Summary
This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it. CBT via telehealth while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) will be compared to CBT via telehealth alone.
Detailed Description
Migraine is the second most disabling disease in the world. Research has primarily focused on treating migraine in adults; however, approximately 10% of children and adolescents have migraine, suggesting that up to 7 million youth are impacted in the United States alone. Given that the majority of youth have migraine symptoms that persist into adulthood, there is a critical need to identify and improve access to the most effective preventive migraine treatments for this population as a means of reducing the long-term healthcare burden and functional impairment of this illness. This comparative effectiveness study will test CBT while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) to CBT alone. Participants will be involved in the study for approximately 28 weeks, with the first 4 weeks being a baseline period and the next 8 weeks involving six telehealth CBT sessions for both study groups (CBT while taking a clinically-prescribed pill-based prevention therapy \[amitriptyline\] compared to CBT alone), and dose titration of clinically-prescribed medication (amitriptyline) for the CBT + clinically-prescribed, pill-based prevention therapy (amitriptyline) group. During the remaining 16 weeks the participants will maintain the dose of medication (in the CBT + clinically-prescribed, pill-based prevention therapy (amitriptyline) group) and attend "booster" CBT sessions held three times over 4 months.
Eligibility Criteria
Age Range: 10 years to 17 years
Interventions
CBT
Amitriptyline
Conditions
Locations
University of Alabama at Birmingham Children's of Alabama
Birmingham, Alabama 35233
United States
Phoenix Children's Hospital - Barrow Neurological Institute
Phoenix, Arizona 85016-7710
United States
University of California San Francisco
San Francisco, California 94115
United States
University of Colorado/Children's Hospital Colorado
Aurora, Colorado 80045
United States
Nemours Children's Health System
Wilmington, Delaware 19810
United States
Clinical Integrative Research Center of Atlanta, Inc
Atlanta, Georgia 30328
United States
University of Louisville Health/Norton
Louisville, Kentucky 40292
United States
Louisiana State Univ/Children's Hospital of New Orleans
New Orleans, Louisiana 70118-5720
United States
Dent Neurological Institute
Amherst, New York 14226
United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229
United States
Nationwide Childrens
Columbus, Ohio 43205
United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania 19104
United States
University of Tennessee Health Science Center/ LeBonheur Children's Hospital
Memphis, Tennessee 38103
United States
Dell Children's Hospital-UT Health
Austin, Texas 78712
United States
Marshall Health
Huntington, West Virginia 25701
United States